We advance human health and well-being by providing an extensive portfolio of in-vitro diagnostic (IVD) systems, reagent kits, and software used by thousands of hospitals and laboratories worldwide. Most notably, Waters delivers technologies for newborn screening, an area of clinical diagnostics that has made a healthy adult life possible for millions.
Mass spectrometry (MS) is more powerful than ever. Modern clinical MS systems deliver extraordinary analytical sensitivity, selectivity, and quantitative performance, opening the door to broader test menus with lower detection limits. With capabilities like these, it’s tempting to ask a simple question: Does chromatography still matter as much as it used to? The short answer…
The Waters MassTrak Immunosuppressant Calibrator, Control, and Internal Standard Sets, soon available, are developed to help laboratories utilize LC-MS/MS with confidence in their assay results.
Our MassTrak IVD solutions provide customers with a range of instrumentation, reagent kits and informatics that can be configured to support laboratory workflows ensuring regulatory compliance.
The Waters Chemistry Technical Service Group is made up of world-class chromatography experts with an ability to uncover ways that labs can be made more robust and reliable.
Accurate screening for extractables and leachables (E&Ls) is imperative for consumer safety, no matter the product. Be it a pharmaceutical, an item of food packaging, or a medical device, consumers place their trust in manufacturers to protect them from the thousands of potentially harmful chemicals that can leach into their products.
Learn more about the practice of newborn screening as we unravel the science behind it in our monthly Renata Newborn Screening Podcast series.
Digging deep into the human biome, Professor Yoshiya Oda of the Graduate School of Medicine at the University of Tokyo looks to ion mobility technology to uncover deposits of insight It’s an established fact that the more people age, the more they tend to engage with health care providers than they did when they were…
Summer break is coming to a close and the thought of fall quickly approaching hangs heavy in the air. The mornings are cool and pleasant, perfect for sleeping. And, here I am, sipping coffee at 5:30AM. Why is it that on mornings like this, when most of the world is asleep, so many biomedical researchers are…
After completing my undergraduate degree, I began work at the New England Newborn Screening Program (NENBS) in Jamaica Plain, Massachusetts. It wasn’t long before I realized the magnitude of the job I held in serving the public and my role in the life-saving tests that the program performed. The NENBS program consists of five testing…
It was to be my third outing to the Association of Public Health Laboratories (APHL) Newborn Screening and Genetic Testing Symposium (NBSGTS), this being the 27th meeting of its kind, bringing some 500 members of the screening and genetics community to the jewel of Lake Michigan, The Windy City, The City With Big Shoulders, Chi-Town:…
Newborn screening for inherited disorders has been heralded as one of the 10 greatest public health achievements of the first decade of the 21st century.1 The ability to pre-symptomatically identify newborn babies at risk of developing endocrine, hematologic, and metabolic disorders has dramatically improved or saved thousands of lives (and saved the healthcare system millions…
We perform a study using Symphony Data Pipeline software in combination with Elucidata’s MSConvert and EIMaven to automate data processing in the comparison of 2D and 3D in vitro cultures in non-small-cell lung carcinoma.